两岁以下儿童免疫接种后的不良事件:北印度的一项前性观察研究
Sneha Mittal1, Cms Rawat2, Amit Gupta3
1Department of Community Medicine, Soban Singh Jeena Government Institute of Medical Science and Research, Almora, IND.
Cureus
|June 2, 2023
概括
这项研究发现,在两岁以下的儿童免疫接种后,轻微不良事件 (AEFI) 的发生率很高,发烧是最常见的. 没有观察到严重的AEFI,突出显示了疫苗的安全性.
科学领域:
- 儿科健康 儿科健康
- 免疫接种安全 免疫安全
- 公共卫生 公共卫生
背景情况:
- 疫苗接种是儿童生存的关键干预措施.
- 免疫接种后的不良事件 (AEFI) 可以侵蚀公众的信任并降低疫苗接种率.
- 评估AEFI发病率对于保持免疫计划完整性至关重要.
研究的目的:
- 确定两岁以下儿童免疫接种后不良事件 (AEFI) 的发生率.
- 在北印度人口中识别常见的AEFI和相关疫苗.
主要方法:
- 印度Uttarakhand的一个前性,基于社区的观察性研究.
- 包括255名两岁以下的儿童.
- 在接种疫苗后的第8天和第30天进行家庭访问,对AEFI进行监测.
主要成果:
- 在152名儿童中报告了212例AEFI;每100剂疫苗剂量发生率为33.0例.
- 大多数AEFI发生在0-1岁的婴儿身上.
- 发烧 (47.6%) 和胀 (25.0%) 是最常见的AEFI;Pentavalent + OPV疫苗与较高的AEFI率有关.
结论:
- 虽然报告的AEFI的发生率很高,但所有事件都是轻微的.
- 在研究队列中没有发现免疫接种后的严重不良事件.
- 持续公众和专业人士对AEFI报告的认识对于疫苗安全至关重要.
更多相关视频
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
3.6K
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
17.0K
相关概念视频
Vaccinations
44.9K
Overview
44.9K
Immunodeficiency Diseases
1.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.0K
Pharmacovigilance
916
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
916
Development of Immunocompetence
369
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
369
Allergic Reactions
27.9K
Overview
27.9K
Allergic Drug Reactions
901
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
901
